Rankings
▼
Calendar
INVA Q1 2016 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena
INVA
Innoviva, Inc.
$1B
Q1 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$24M
Gross Profit
$24M
98.4% margin
Operating Income
$18M
72.5% margin
Net Income
$4M
18.3% margin
EPS (Diluted)
$0.04
Cash Flow
Operating Cash Flow
$7M
Free Cash Flow
$7M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$388M
Total Liabilities
$750M
Stockholders' Equity
-$362M
Cash & Equivalents
$152M
← FY 2016
All Quarters
Q2 2016 →